Cintas Corporation (CTAS) Stock Forecast
Data as of May 2, 2026Industrials · Current price $170.01 (-2.69%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 11, 2026 | Andrew Wittmann | Robert W. Baird | $250.00 | +47.0% |
| Nov 25, 2025 | Jason Haas | Wells Fargo | $185.00 | +8.8% |
| Nov 11, 2025 | Oliver Davies | Redburn Partners | $184.00 | +8.2% |
| Dec 20, 2024 | Jason Haas | Wells Fargo | $184.00 | +8.2% |
| Dec 12, 2024 | Toni Kaplan | Morgan Stanley | $202.00 | +18.8% |
| Sep 26, 2024 | Joshua Chan | UBS | $240.00 | +41.2% |
| Sep 25, 2024 | George Tong | Goldman Sachs | $212.00 | +24.7% |
| Sep 25, 2024 | Ashish Sabadra | RBC Capital | $181.00 | +6.5% |
| Sep 24, 2024 | Manav Patnaik | Barclays | $210.00 | +23.5% |
| Sep 24, 2024 | Toni Kaplan | Morgan Stanley | $156.25 | -8.1% |
| Sep 24, 2024 | Jason Haas | Wells Fargo | $183.75 | +8.1% |
| Sep 17, 2024 | Jasper Bibb | Truist Financial | $225.00 | +32.3% |
| Sep 11, 2024 | Caydee Blankenship | CFRA | $170.00 | -0.0% |
| Aug 12, 2024 | Jason Haas | Wells Fargo | $183.75 | +8.1% |
| Aug 9, 2024 | Oliver Davies | Redburn Partners | $167.50 | -1.5% |
| Jul 19, 2024 | Shlomo Rosenbaum | Stifel Nicolaus | $199.50 | +17.3% |
| Jul 19, 2024 | Toni Kaplan | Morgan Stanley | $156.25 | -8.1% |
| Jul 19, 2024 | Jasper Bibb | Truist Financial | $212.50 | +25.0% |
| Jul 19, 2024 | Andrew Wittmann | Robert W. Baird | $193.75 | +14.0% |
| Mar 28, 2024 | Ashish Sabadra | RBC Capital | $181.25 | +6.6% |
Top Analysts Covering CTAS
CTAS vs Sector & Market
| Metric | CTAS | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.20 | 2.41 | 2.41 |
| Analyst Count | 10 | 8 | 18 |
| Target Upside | +31.4% | +84.9% | +14.9% |
| P/E Ratio | 35.87 | 28.14 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-05-31 | $11.20B | $11.24B | $11.26B | 16 |
| 2026-08-28 | $2.89B | $2.93B | $2.97B | 8 |
| 2026-11-28 | $2.97B | $3.00B | $3.03B | 4 |
| 2027-02-28 | $3.00B | $3.03B | $3.06B | 4 |
| 2027-05-28 | $3.06B | $3.09B | $3.13B | 4 |
| 2027-05-31 | $11.94B | $12.07B | $12.15B | 15 |
| 2027-08-28 | $3.09B | $3.12B | $3.15B | 4 |
| 2027-11-28 | $3.16B | $3.19B | $3.23B | 4 |
| 2028-02-28 | $3.17B | $3.20B | $3.24B | 3 |
| 2028-05-28 | $3.26B | $3.29B | $3.32B | 3 |
| 2028-05-31 | $12.91B | $12.91B | $12.92B | 12 |
| 2029-05-31 | $13.58B | $13.73B | $13.80B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-05-31 | $4.86 | $4.89 | $4.92 | 12 |
| 2026-08-28 | $1.27 | $1.33 | $1.39 | 8 |
| 2026-11-28 | $1.34 | $1.36 | $1.38 | 3 |
| 2027-02-28 | $1.35 | $1.37 | $1.38 | 3 |
| 2027-05-28 | $1.37 | $1.38 | $1.40 | 3 |
| 2027-05-31 | $5.36 | $5.43 | $5.51 | 11 |
| 2027-08-28 | $1.43 | $1.45 | $1.47 | 3 |
| 2027-11-28 | $1.47 | $1.48 | $1.50 | 3 |
| 2028-02-28 | $1.44 | $1.46 | $1.48 | 4 |
| 2028-05-28 | $1.47 | $1.49 | $1.51 | 4 |
| 2028-05-31 | $5.67 | $6.02 | $6.30 | 7 |
| 2029-05-31 | $6.75 | $6.85 | $6.90 | 2 |
Frequently Asked Questions
What is the analyst consensus for CTAS?
The consensus among 10 analysts covering Cintas Corporation (CTAS) is Hold with an average price target of $219.80.
What is the highest price target for CTAS?
The highest price target for CTAS is $250.00, set by Andrew Wittmann at Robert W. Baird on 2026-03-11.
What is the lowest price target for CTAS?
The lowest price target for CTAS is $22.63, set by Toni Kaplan at Morgan Stanley on 2022-07-15.
How many analysts cover CTAS?
10 analysts have issued ratings for Cintas Corporation in the past 12 months.
Is CTAS a buy or sell right now?
Based on 10 analyst ratings, CTAS has a consensus rating of Hold (3.20/5) with a +31.4% upside to the consensus target of $219.80.
What are the earnings estimates for CTAS?
Analysts estimate CTAS will report EPS of $4.89 for the period ending 2026-05-31, with revenue estimated at $11.24B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.